$ATRX Churning nicely here in the .07s - .08s range, we could see a rebound to test the .12 - .15 level. Nice LOI News out Last week: Adhera Therapeutics Signs Letter of Intent to Acquire CD71-Targeted Cancer Therapy Paclitaxel Gallium Transferrin. https://finance.yahoo.com/news/adhera-therapeutics-signs-letter-intent-131500161.html https://investorshub.advfn.com/uimage/uploads/2022/7/25/ykumwATRX.png